221 related articles for article (PubMed ID: 18492875)
1. Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation.
Minami Y; Chung H; Kudo M; Kitai S; Takahashi S; Inoue T; Ueshima K; Shiozaki H
AJR Am J Roentgenol; 2008 Jun; 190(6):W335-41. PubMed ID: 18492875
[TBL] [Abstract][Full Text] [Related]
2. Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation.
Minami Y; Kitai S; Kudo M
Eur J Radiol; 2012 Mar; 81(3):e277-80. PubMed ID: 21392916
[TBL] [Abstract][Full Text] [Related]
3. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
[TBL] [Abstract][Full Text] [Related]
4. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
[TBL] [Abstract][Full Text] [Related]
5. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.
Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN
J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography.
Minami Y; Kudo M; Kawasaki T; Chung H; Ogawa C; Shiozaki H
AJR Am J Roentgenol; 2004 Jul; 183(1):153-6. PubMed ID: 15208130
[TBL] [Abstract][Full Text] [Related]
8. Virtual sonographic radiofrequency ablation of hepatocellular carcinoma visualized on CT but not on conventional sonography.
Hirooka M; Iuchi H; Kumagi T; Shigematsu S; Hiraoka A; Uehara T; Kurose K; Horiike N; Onji M
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S255-60. PubMed ID: 16632685
[TBL] [Abstract][Full Text] [Related]
9. Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial.
Minami Y; Kudo M; Chung H; Kawasaki T; Yagyu Y; Shimono T; Shiozaki H
AJR Am J Roentgenol; 2007 Feb; 188(2):489-94. PubMed ID: 17242259
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography.
Nakai M; Sato M; Sahara S; Takasaka I; Kawai N; Minamiguchi H; Tanihata H; Kimura M; Takeuchi N
Cardiovasc Intervent Radiol; 2009 Jan; 32(1):62-9. PubMed ID: 18987911
[TBL] [Abstract][Full Text] [Related]
11. Preoperative RFA simulation for liver cancer using a CT virtual ultrasound system.
Kudo K; Moriyasu F; Mine Y; Miyata Y; Sugimoto K; Metoki R; Kamamoto H; Suzuki S; Shimizu M; Miyahara T; Yokoi M; Horibe T; Yamagata H
Eur J Radiol; 2007 Feb; 61(2):324-31. PubMed ID: 17049791
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the ablated area after radiofrequency ablation by contrast-enhanced sonography; comparison with virtual sonography with magnetic navigation.
Koda M; Mandai M; Matono T; Sugihara T; Nagahara T; Ueki M; Ohyama K; Hosho K; Murawaki Y
Clin Imaging; 2010; 34(1):60-4. PubMed ID: 20122522
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images.
Minami Y; Kudo M; Chung H; Inoue T; Takahashi S; Hatanaka K; Ueda T; Hagiwara H; Kitai S; Ueshima K; Fukunaga T; Shiozaki H
Oncology; 2007; 72 Suppl 1():111-6. PubMed ID: 18087191
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult cases.
Inoue T; Minami Y; Chung H; Hayaishi S; Ueda T; Tatsumi C; Takita M; Kitai S; Hatanaka K; Ishikawa E; Yada N; Hagiwara S; Ueshima K; Kudo M
Oncology; 2010 Jul; 78 Suppl 1():94-101. PubMed ID: 20616590
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound fusion imaging of hepatocellular carcinoma: a review of current evidence.
Minami Y; Kudo M
Dig Dis; 2014; 32(6):690-5. PubMed ID: 25376285
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of CT/MR-US fusion imaging for radiofrequency ablation of hepatic nodules.
Lee JY; Choi BI; Chung YE; Kim MW; Kim SH; Han JK
Eur J Radiol; 2012 Sep; 81(9):2281-9. PubMed ID: 21937177
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography.
Dill-Macky MJ; Asch M; Burns P; Wilson S
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S287-95. PubMed ID: 16632690
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.
Yang W; Chen MH; Yin SS; Yan K; Gao W; Wang YB; Huo L; Zhang XP; Xing BC
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S275-83. PubMed ID: 16632688
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: comparison of effects of thermal protection and therapeutic efficacy.
Kang TW; Rhim H; Lee MW; Kim YS; Choi D; Lee WJ; Lim HK
AJR Am J Roentgenol; 2011 Apr; 196(4):907-13. PubMed ID: 21427344
[TBL] [Abstract][Full Text] [Related]
20. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
Yoon JH; Lee EJ; Cha SS; Han SS; Choi SJ; Juhn JR; Kim MH; Lee YJ; Park SJ
J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
